Dr. Christopher Vije, MD
What this data tells you about Dr. Vije
Dr. Christopher Vije is an anesthesiology in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Vije performed 16,312 Medicare services across 3,205 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vije received a total of $14,879 from 42 pharmaceutical and/or device companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vije is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 6,119 | $0 | $3 |
| Contrast dye for imaging, lower concentration | 2,637 | $0 | $1 |
| Injection, propofol, 10 mg | 1,395 | $0 | $0 |
| Extended-release steroid injection (Zilretta) | 1,248 | $13 | $53 |
| Office visit, established patient (20-29 min) | 821 | $66 | $146 |
| Office visit, established patient (30-39 min) | 370 | $101 | $217 |
| Injection, methylprednisolone acetate, 80 mg | 349 | $9 | $20 |
| Injection, midazolam hydrochloride, per 1 mg | 329 | $0 | $1 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 272 | $9 | $78 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 236 | $41 | $201 |
| X-ray of lower and sacral spine, 2-3 views | 220 | $33 | $90 |
| X-ray of spine, 1 view | 200 | $20 | $56 |
| Injection, ketorolac tromethamine, per 15 mg | 191 | $0 | $4 |
| Injection, fentanyl citrate, 0.1 mg | 191 | $1 | $4 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 163 | $227 | $783 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 161 | $201 | $524 |
| Fluoroscopic guidance for needle placement | 150 | $90 | $239 |
| New patient office visit (45-59 min) | 133 | $123 | $331 |
| Joint injection, major joint | 128 | $57 | $210 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 88 | $92 | $267 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 86 | $355 | $1,268 |
| X-ray of joint between lower spine and hip bone, 1-2 views | 80 | $27 | $86 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 61 | $146 | $589 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 59 | $194 | $757 |
| Injection, methylprednisolone acetate, 40 mg | 57 | $6 | $11 |
| Injection of substance into lower spine canal using imaging guidance | 54 | $204 | $746 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 54 | $104 | $379 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 46 | $214 | $573 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 46 | $42 | $167 |
| X-ray of upper spine, 2-3 views | 43 | $33 | $85 |
| Injection of substance into middle or upper spine canal using imaging guidance | 41 | $212 | $760 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 30 | $182 | $700 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 29 | $94 | $347 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 28 | $724 | $2,757 |
| Insertion of spinal neurostimulator electrode array through skin | 26 | $246 | $4,093 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 24 | $353 | $1,279 |
| Ultrasonic guidance for needle placement | 22 | $46 | $206 |
| Insertion of needle into vein (3 years or older) | 20 | $7 | $52 |
| Treatment of broken lower spine bone with placement of stabilizing device | 19 | $4,830 | $22,620 |
| Insertion of spinal neurostimulator generator or receiver | 18 | $182 | $1,121 |
| X-ray of lower and sacral spine, minimum of 4 views | 18 | $10 | $126 |
| New patient office visit, complex (60-74 min) | 18 | $167 | $415 |
| Injection of trigger points, 3 or more muscles | 16 | $43 | $194 |
| Treatment of broken spine bone with stabilizing device, each additional segment | 16 | $2,496 | $13,730 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for anesthesiology in TX.
Geographic Context
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vije is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vije experienced with injection, bupivicaine, not otherwise specified, 0.5 mg?
Does Dr. Vije receive payments from pharmaceutical companies?
How do Dr. Vije's costs compare to other anesthesiologys in Austin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology